China Resources Pharmaceutical Group
3320.HK
#2882
Rank
A$7.20 B
Marketcap
$1.15
Share price
1.09%
Change (1 day)
28.01%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2022: A$52.09 Billion

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is A$52.09 Billion. In 2022 the company made a revenue of A$52.09 Billion an increase over the revenue in the year 2021 that were of A$48.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2013 to 2022

Annual revenue

Year Revenue Change
2022A$52.09 B7.09%
2021A$48.64 B17.47%
2020A$41.41 B-1.52%
2019A$42.05 B8.38%
2018A$38.80 B9.69%
2017A$35.37 B9.28%
2016A$32.37 B6.86%
2015A$30.29 B8.05%
2014A$28.03 B16.04%
2013A$24.15 B